Delayed-type hypersensitivity reaction to the meta-cresol component of insulin

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 2, 2007, Pages 194-195

  Kim, Dennis ^a   Baraniuk, James ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; META CRESOL; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CASE REPORT; DELAYED HYPERSENSITIVITY; DIABETES MELLITUS; EOSINOPHIL COUNT; FEMALE; HUMAN; INJECTION SITE PRURITUS; PATCH TEST; PRIORITY JOURNAL; PRURITUS; RADIOALLERGOSORBENT TEST;

EID: 34547955500     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60645-X     Document Type: Article

References (10)

1. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care. 1993;16(suppl 3): 155-65.
2. Wonders J, Eekhoff EM, Heine R, Bruynzeel DP, Rustemeyer T. Insulin allergy: background, diagnosis and treatment [in Dutch]. Ned Tijdschr Geneeskd. 2005;149:2783-2788.
3. US Food and Drug Administration. FDA Consumer magazine. January-February 2002. Available at: http://www.fda.gov/fdac/ features/2002/chrt_insulin.html.
4. Mirouze J, Monnier L, Rodier M, Balducchi JP, Orsetti A, Clot J. Chronic insulin urticaria: therapeutic efficacy and good tolerability of human insulins. Nouv Presse Med. 1982;11: 3121-3124.
5. Wurzburger MI, Prelevic GM, Despotovic N, Vuckovic S, Brkic SD, Bozovic M, Nastic-Miric D. Delayed-type allergy against various insulin preparations including human semisynthetic insulin. Ann Allergy. 1987;59:44-47.
6. Rajpar SF, Foulds IS, Abdullah A, Maheshwari M. Severe adverse cutaneous reaction to insulin due to cresol sensitivity. Contact Dermatitis. 2006;55:119-120.
7. Bruze M, Zimerson E. Contact allergy to o-cresol-a sensitizer in phenol-formaldehyde resin. Am J Contact Dermat. 2002;13: 198-200.
8. Bruze M, Fregert S, Zimerson E. Contact allergy to phenolformaldehyde resins. Contact Dermatitis. 1985;12:81-86.
9. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4:661-667.
10. Anderson A. Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol. Int J Toxicol. 2006;25(suppl 1): 29-127.